Literature DB >> 9517869

A mathematical model for the determination of the optimum value of the treatment threshold for a continuous risk factor.

M Cucherat1, J P Boissel.   

Abstract

Hypercholesterolemia or hypertension are continuous risk factors for coronary heart disease. When a preventive action is carried out against such a risk factor, it is necessary to specify a risk factor level value, named the treatment threshold, above which a subject should be treated. But a non-arbitrary determination of this threshold value is impossible from the epidemiological data. A method for the non-arbitrary determination of the treatment threshold value is presented, based upon mathematical modelling of the clinical and economics consequences of the prevention policy in the whole population. In a cost-effectiveness approach, the model was used to estimate the cost per coronary event prevented according to the threshold value for blood cholesterol. It was found that a minimum in this outcome proposed as the optimum treatment threshold. It is possible, from a public health point of view, to determine an optimum, non-arbitrary treatment threshold value in the prevention of coronary heart disease with cholesterol-lowering interventions. The model proposed here could be useful in decision making processes.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9517869     DOI: 10.1023/a:1007423730270

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  15 in total

1.  An analysis of randomized trials evaluating the effect of cholesterol reduction on total mortality and coronary heart disease incidence.

Authors:  I Holme
Journal:  Circulation       Date:  1990-12       Impact factor: 29.690

2.  Consensus conference. Lowering blood cholesterol to prevent heart disease.

Authors: 
Journal:  JAMA       Date:  1985-04-12       Impact factor: 56.272

Review 3.  Fenofibrate. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in dyslipidaemia.

Authors:  J A Balfour; D McTavish; R C Heel
Journal:  Drugs       Date:  1990-08       Impact factor: 9.546

4.  Wine, alcohol, platelets, and the French paradox for coronary heart disease.

Authors:  S Renaud; M de Lorgeril
Journal:  Lancet       Date:  1992-06-20       Impact factor: 79.321

5.  Strategies for the prevention of coronary heart disease: a policy statement of the European Atherosclerosis Society.

Authors: 
Journal:  Eur Heart J       Date:  1987-01       Impact factor: 29.983

6.  [Incidence and evaluation of the risk of coronary disease. Prospective study in Paris].

Authors:  J L Richard; P Ducimetière; G Bonnaud; J R Claude; J Lellouch; D Schwartz; J Di Mattéo
Journal:  Arch Mal Coeur Vaiss       Date:  1977-05

7.  Comparison of cardiovascular risk factor levels in two French populations: Haute-Garonne (Toulouse) and Bas-Rhin (Strasbourg).

Authors:  P Douste-Blazy; J B Ruidavets; D Arveiler; A Bingham; R Camaré; P Schaffer; M A Aby; J L Richard
Journal:  Acta Med Scand Suppl       Date:  1988

8.  Coronary heart disease in middle-aged Frenchmen. Comparisons between Paris Prospective Study, Seven Countries Study, and Pooling Project.

Authors:  P Ducimetiere; J L Richard; F Cambien; R Rakotovao; J R Claude
Journal:  Lancet       Date:  1980-06-21       Impact factor: 79.321

9.  Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group.

Authors:  J Shepherd; S M Cobbe; I Ford; C G Isles; A R Lorimer; P W MacFarlane; J H McKillop; C J Packard
Journal:  N Engl J Med       Date:  1995-11-16       Impact factor: 91.245

Review 10.  Blood pressure, stroke, and coronary heart disease. Part 2, Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context.

Authors:  R Collins; R Peto; S MacMahon; P Hebert; N H Fiebach; K A Eberlein; J Godwin; N Qizilbash; J O Taylor; C H Hennekens
Journal:  Lancet       Date:  1990-04-07       Impact factor: 79.321

View more
  4 in total

Review 1.  Cost effectiveness of statins in coronary heart disease.

Authors:  Oscar H Franco; Anna Peeters; Caspar W N Looman; Luc Bonneux
Journal:  J Epidemiol Community Health       Date:  2005-11       Impact factor: 3.710

2.  Comparison of an effect-model-law-based method versus traditional clinical practice guidelines for optimal treatment decision-making: application to statin treatment in the French population.

Authors:  Riad Kahoul; François Gueyffier; Emmanuel Amsallem; Margaret Haugh; Ivanny Marchant; François-Henri Boissel; Jean-Pierre Boissel
Journal:  J R Soc Interface       Date:  2014-11-06       Impact factor: 4.118

Review 3.  Effect model law: an approach for the implementation of personalized medicine.

Authors:  Jean-Pierre Boissel; Riad Kahoul; Draltan Marin; François-Henri Boissel
Journal:  J Pers Med       Date:  2013-08-15

4.  Should malaria treatment be guided by a point of care rapid test? A threshold approach to malaria management in rural Burkina Faso.

Authors:  Zeno Bisoffi; Halidou Tinto; Bienvenu Sodiomon Sirima; Federico Gobbi; Andrea Angheben; Dora Buonfrate; Jef Van den Ende
Journal:  PLoS One       Date:  2013-03-05       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.